Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats. (Q50746144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Yun Song

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Xu Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Li-Yan Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Wei Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mei-Jia Zhu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

3 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

603-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

Protein aggregation diseases: pathogenicity and therapeutic perspectives

29 February 2020

cites work

1 reference

Alzheimer's disease: strategies for disease modification

21 January 2018

1 reference

The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

21 January 2018

1 reference

WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity

21 January 2018

1 reference

Assessing the contribution of inflammation in models of Alzheimer's disease

21 January 2018

1 reference

The therapeutic effects of Rho-ROCK inhibitors on CNS disorders

21 January 2018

1 reference

Rho kinase (ROCK) inhibitors and their application to inflammatory disorders

21 January 2018

1 reference

Inflammation: beneficial or detrimental after spinal cord injury?

21 January 2018

1 reference

Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice

21 January 2018

1 reference

Peripheral delivery of a ROCK inhibitor improves learning and working memory

21 January 2018

1 reference

Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial

21 January 2018

1 reference

Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress

21 January 2018

1 reference

ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells

21 January 2018

1 reference

Increased dendrite branching in AbetaPP/PS1 mice and elongation of dendrite arbors by fasudil administration

21 January 2018

1 reference

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho

21 January 2018

1 reference

Prolonged lesional expression of RhoA and RhoB following spinal cord injury.

21 January 2018

1 reference

Nuclear factor-kappaB activation: from bench to bedside

21 January 2018

1 reference

Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB.

21 January 2018

1 reference

The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

12 December 2020

Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities

1 reference

12 December 2020

Inflammatory processes in Alzheimer's disease

1 reference

12 December 2020

Dexamethasone suppresses infiltration of RhoA+ cells into early lesions of rat traumatic brain injury

1 reference

12 December 2020

Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats

1 reference

12 December 2020

Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion

1 reference

12 December 2020

Nogo-66 receptor activation inhibits neurite outgrowth and increases β-amyloid protein secretion of cortical neurons

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23638992

1 reference